Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines. Intravenous magnesium sulphate, salbutamol and aminophylline all have advocates but what order, speed of delivery or dosage is left up to the individual physician treating the patient. A child in respiratory failure was given a large, fast dose of intravenous magnesium sulphate before intravenous salbutamol which relaxed bronchial smooth muscle immediately and tracheal intubation and lung ventilation was avoided. Justification for this treatment is discussed
Editor’s key points † Current guidelines do not adequately cover the management of life-threatening ...
Asthma in children constitutes a well-known respiratory condition with significant mortality. In poo...
A double blind randomized controlled trial was conducted to examine the efficacy of nebulized magnes...
Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines...
Nebulization with B-agonist and administration of systemic corticosteroids are standard treatments f...
Background Intravenous magnesium can cause bronchodilation in treatment of severe asthma, however it...
Objectives: To describe the role of intravenous magnesium sulfate (MgSO4) as therapy for acute sever...
Purpose of review The role of magnesium sulfate (MgSO4) in the treatment of acute asthma is not ...
A prospective double-blind placebo controlled trial carried out on 60 children known to be asthmatic...
Objective: The outcomes were mostly debatable; consequently researchers led the current investigatio...
BACKGROUND: Asthma is the most common pediatric chronic disease and currently affects 7.1 million ch...
Randomized, single blind, case controlled clinical trial conducted in Khartoum Children’s Emergency...
Objective: Continued enthusiasm for intravenous magnesium sulfate to use it in many different signs ...
SummaryBackgroundTreatment of acute asthma is based on rapid reversal of bronchospasm and airway inf...
Though intravenous (IV) Magnesium Sulphate (MgS04) has additive effect to beta-2 ago-nists, its addi...
Editor’s key points † Current guidelines do not adequately cover the management of life-threatening ...
Asthma in children constitutes a well-known respiratory condition with significant mortality. In poo...
A double blind randomized controlled trial was conducted to examine the efficacy of nebulized magnes...
Acute severe asthma when respiratory failure is imminent is not addressed in world asthma guidelines...
Nebulization with B-agonist and administration of systemic corticosteroids are standard treatments f...
Background Intravenous magnesium can cause bronchodilation in treatment of severe asthma, however it...
Objectives: To describe the role of intravenous magnesium sulfate (MgSO4) as therapy for acute sever...
Purpose of review The role of magnesium sulfate (MgSO4) in the treatment of acute asthma is not ...
A prospective double-blind placebo controlled trial carried out on 60 children known to be asthmatic...
Objective: The outcomes were mostly debatable; consequently researchers led the current investigatio...
BACKGROUND: Asthma is the most common pediatric chronic disease and currently affects 7.1 million ch...
Randomized, single blind, case controlled clinical trial conducted in Khartoum Children’s Emergency...
Objective: Continued enthusiasm for intravenous magnesium sulfate to use it in many different signs ...
SummaryBackgroundTreatment of acute asthma is based on rapid reversal of bronchospasm and airway inf...
Though intravenous (IV) Magnesium Sulphate (MgS04) has additive effect to beta-2 ago-nists, its addi...
Editor’s key points † Current guidelines do not adequately cover the management of life-threatening ...
Asthma in children constitutes a well-known respiratory condition with significant mortality. In poo...
A double blind randomized controlled trial was conducted to examine the efficacy of nebulized magnes...